David M. Mott, Director at NOVAVAX INC (NVAX), sold 48,722 shares at $254.46 ($12.3M) on 2021-09-23, disclosed to the SEC on 2021-09-24.
Open-market sale of $12.3M NVAX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $251.32 | 5,728 | $1.4M | 11.7% |
| 2 | $251.32 | 5,728 | $1.4M | 11.7% |
| 3 | $252.56 | 7,557 | $1.9M | 15.5% |
| 4 | $252.56 | 7,557 | $1.9M | 15.5% |
| 5 | $253.46 | 7,744 | $2.0M | 15.9% |
| 6 | $253.46 | 7,744 |
| $2.0M |
| 15.9% |
| 7 | $254.46 | 2,732 | $695K | 5.6% |
| 8 | $254.46 | 2,732 | $695K | 5.6% |
| 9 | $255.38 | 1,200 | $306K | 2.5% |
| Total | $252.84 avg | 48,722 | $12.3M | 100% |
| Filing → |
| ARDX | BUY | 2025-06-11 | $738K | — | Filing → |
| ARDX | BUY | 2025-05-19 | $329K | — | Filing → |
| ARDX | BUY | 2025-05-05 | $3.2M | — | Filing → |